8-K - 4D Molecular Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Securities Issuance

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

3.02

Unregistered Sales of Equity Securities. Issuance of Pre-Funded Warrants in Exchange for Common Stock On January 22, 2026, 4D Molecular Therapeutics, Inc. (the

Securities Issuance

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 4.1 Form of Pre-Funded Warrant issued in conjunction with January 2026 exchange 104

Exhibits Only

Exhibits (2)

4.1

EX-4.1

8-K